New Drug and Biologics 2021: Therapies Reaching the Home and Alternate Site Infusion Space
-
Register
- Prices available after logging in
This program will provide education related to the 2021 FDA-approved drugs that are pertinent to the home and alternate site infusion industry because they are administered by intravenous infusion or injection. Each drug (17 total) will receive a brief review discussing its indication as well as incidence and clinical course of disease(s) treated. Reviews will also cover the drug’s mechanism of action, the clinical trials leading to FDA approval, home infusion pharmacy considerations for storage, compounding and administration of the drug; nursing and patient education considerations, and pricing information.
Learning Objectives:
- Review the new FDA approved drugs from 2021 that relate to the home and specialty infusion industry.
- Understand the indications for the new FDA drugs approved in 2021.
- Review the clinical characteristics of the new FDA drugs approved in 2021.
- Discuss clinical, compounding, administration, and nursing considerations for the new FDA approved drugs in 2021.
Ryan Garst, PharmD, MBA, IgCP, BCSCP
Sr Director Clinical Services
NHIA
Ryan Garst, Pharm D, MBA, BCSCP is the Senior Director of Clinical Services at the National Home Infusion Association. Garst has almost 15 years of experience in home infusion and nearly twenty years of experience in pharmacy clinical and operational leadership and management, information technology, sales, and clinical practice experience. At NHIA, Garst is responsible for clinical education and services, Infusion Magazine Clinical Editor, and oversees a variety of programs administered by the National Home Infusion Foundation including the industry resident program, the National Benchmarking Program, and clinical trials and research. Prior to joining NHIA, Garst served on a variety of committees for the association and participated in numerous annual conferences. Garst holds a Doctor of Pharmacy degree from Ohio Northern University and a Master of Business Administration from Kent State University and is Board Certified in Sterile Compounded Preparations via BPS.
No Disclosures to Report
Key:
Complete
Next
Failed
Available
Locked